Antibodies News and Research

RSS

New bird flu vaccine promises to offer cross-protection

Early clinical trials of a new bird flu vaccine have produced promising results and a phase 3 trial of the cell-based H5N1 flu vaccine is expected to take place early next year.

4 Oct 2006

Multispectral imaging of clinically relevant cellular targets in tonsil and lymphoid tissue using semiconductor quantum dots

When pathologists examine tissue samples in order to diagnose cancer of the lymphatic system, they examine the relative amounts of a group of proteins known as Cluster of Differentiation markers.

25 Sep 2006

Carbon nanotube amplification strategies for highly sensitive immunodetection of cancer biomarkers

In an attempt to increase the sensitivity of cancer biomarker detection and to decrease the need for large samples from which to detect those molecules, a multi-institutional research team has shown that a "forest" of single-walled carbon nanotubes can be used to detect lower levels of the prostate specific antigen (PSA) than is possible using the current commercial assay.

25 Sep 2006

Smokers may be at greater risk of HIV infection than non-smokers

Cigarette smoking has already been linked to a higher than normal chance of contracting other infections generally, including those that have been sexually transmitted.

21 Sep 2006

Cell detachment model for an antibody-based microfluidic cancer screening system

In the quest to detect more types of cancers at ever earlier stages, researchers have been stymied by a lack of cell surface markers that distinguish in a clear-cut manner between healthy and malignant cells.

19 Sep 2006

Live H5N1 avian flu vaccines show promise

When tested in mice and ferrets, experimental vaccines based on live, weakened versions of different strains of the H5N1 avian influenza virus were well-tolerated and protected the animals from a deadly infection with naturally occurring H5N1 flu viruses.

13 Sep 2006

Live H5N1 avian flu virus vaccines show protection in animal studies

12 Sep 2006

Nanocantilevers as future disease detectors

Researchers at Purdue University have made a discovery about the behavior of tiny structures called nanocantilevers that could be crucial in designing a new class of ultra-small sensors for detecting viruses, bacteria, and other pathogens.

12 Sep 2006

New screening method shows how nanoparticles interact with human cells

Scientists at the Brookhaven National Laboratory have developed a screening method to examine how newly made nanoparticles interact with human cells following exposure for various times and doses. Using this new method, the investigators have been able to visualize how human cells interact with some specific types of carbon nanoparticles.

12 Sep 2006

SemBioSys Genetics granted immunoglobulin related patent

SemBioSys Genetics has announced it has been granted U.S. patent 7,098,383 entitled "Methods for the production of multimeric immunoglobulins, and related compositions".

11 Sep 2006

Trial shows H5N1 vaccine safe and effective

A vaccine in development against the H5N1 influenza virus can produce a safe immune response in healthy people at low doses, according to an article published by The Lancet.

7 Sep 2006

China appears to have beaten the world to a bird flu vaccine

Scientists in China have developed a potential vaccine against the deadly H5N1 bird flu virus currently sweeping across Asia.

7 Sep 2006

New method for attaching tumor-targeting antibodies to the surface of buckyballs

Hollow buckyballs, spherical molecules made of sixty carbon atoms linked to one another like the panels of a soccer ball, have the potential to ferry large doses of anticancer drugs or imaging agents to tumors.

5 Sep 2006

1918 Spanish flu treatment may also be effective for current avian influenza patients

USU faculty have discovered that a treatment for the Spanish Influenza pandemic may also be effective for current Avian Influenza patients.

4 Sep 2006

Emergent BioSolutions awarded $3.8 million to develop anthrax immune globulin therapeutic

Emergent BioSolutions has announced that it has been awarded two grants from the National Institute of Allergy and Infectious Diseases (NIAID) totaling $3.8 million to support the development of the company's anthrax immune globulin (AIG) therapeutic product.

1 Sep 2006

New cell-based targets for treating autoimmune inflammatory diseases

Patients with systemic autoimmune diseases such as lupus and rheumatoid arthritis (RA) often suffer loss of kidney function.

31 Aug 2006

Morphotek granted two European technology patents

Morphotek has announced that the European Patent Office has given a "Decision of Grant" regarding the Company's US Patent 6,921,666 entitled "Methods for Generating Hypermutable Yeast" and US Patent 6,737,268 entitled "A Method for Generating Genetically Altered Antigens."

30 Aug 2006